Huakang Biomedical Holdings Company Limited 8622.HK
8622.HK
Huakang Biomedical Holdings Company Limited 0858.HK
Extrawell Pharmaceutical Holdings Limited 1498.HK
PuraPharm Corporation Limited 0928.HK
King International Investment Limited 8329.HK
Shenzhen Neptunus Interlong Bio-technique Company Limited 0673.HK
China Health Group Limited 2293.HK
Bamboos Health Care Holdings Limited 0575.HK
Regent Pacific Group Limited 8143.HK
Good Fellow Healthcare Holdings Limited 0455.HK
Tianda Pharmaceuticals Limited
Huakang Biomedical Holdings Company Limited 0858.HK
Extrawell Pharmaceutical Holdings Limited 1498.HK
PuraPharm Corporation Limited 0928.HK
King International Investment Limited 8329.HK
Shenzhen Neptunus Interlong Bio-technique Company Limited 0673.HK
China Health Group Limited 2293.HK
Bamboos Health Care Holdings Limited 0575.HK
Regent Pacific Group Limited 8143.HK
Good Fellow Healthcare Holdings Limited 0455.HK
Tianda Pharmaceuticals Limited
Performance
| Periode | 8622.HK | 0858.HK | 1498.HK | 0928.HK | 8329.HK | 0673.HK | 2293.HK | 0575.HK | 8143.HK | 0455.HK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 61.19 % | 100.00 % | -9.57 % | 209.38 % | -48.62 % | 155.00 % | -10.34 % | 45.26 % | 187.03 % | -25.00 % |
| YTD | 182.72 % | 95.92 % | -25.44 % | 125.00 % | -8.02 % | 70.00 % | -22.39 % | 84.00 % | 111.25 % | -21.51 % |
| 1Y | 212.14 % | 100.00 % | -40.14 % | 43.48 % | 13.74 % | -7.27 % | -17.46 % | 53.33 % | 53.64 % | -28.57 % |
| 3Y | 200.00 % | 47.69 % | -54.79 % | 253.57 % | 7.19 % | -59.84 % | -31.58 % | -52.74 % | -26.52 % | -28.19 % |
| 5Y | 434.65 % | -20.66 % | -45.51 % | 6 589.19 % | -59.18 % | 41.67 % | -44.09 % | -77.30 % | -40.49 % | -15.63 % |
| 10Y | 14.89 % | -75.06 % | -89.10 % | -67.00 % | -81.14 % | -80.38 % | -42.22 % | -96.41 % | -94.53 % | -64.94 % |
| From the beginning | 14.89 % | -52.00 % | -88.25 % | -72.11 % | -59.18 % | -98.30 % | -72.92 % | -96.42 % | -99.93 % | -86.50 % |